Daniel Paul Regan
Nessuna posizione attualmente
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Nicole Hadas | F | 51 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | 12 anni |
| Gregory Madison | M | 57 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 17 anni |
| Michael Tarnok | M | 69 | 9 anni | |
| John Butler | M | 59 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | 5 anni |
| James Oliviero | M | 48 | 12 anni | |
| Scott A. Holmes | M | 50 | 3 anni | |
| Sanj Patel | M | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 11 anni |
| Michael Rogers | M | 64 | 2 anni | |
| Jodie Morrison | F | 48 | 2 anni | |
| Karen L. Tubridy | M | 61 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | 2 anni |
| Lorenzo M. Tallarigo | M | 74 | 6 anni | |
| Amy Sullivan | F | 54 | 4 anni | |
| Mark Enyedy | M | 60 | 1 anni | |
| Brian Schiller | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 anni |
| Jack Kaye | M | 80 | 10 anni | |
| Bryan Yoon | M | 46 | 4 anni | |
| Julie Feder | F | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Michael Halpin | M | 62 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 anni |
| Gloria Matthews | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 anni |
| Jean S. K. Lee | M | - |
University of Massachusetts
| 4 anni |
| Linda Bain | F | 53 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 anni |
| Steven Burke | M | 63 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| John Neylan | M | 70 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 anni |
| Lora L. Pike | F | - | - | |
| Richard Gregory | M | 66 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
University of Massachusetts
| 15 anni |
| Ronald Bentsur | M | 58 | 6 anni | |
| Brian Adams | M | 50 | 4 anni | |
| Peter T. Traynor | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Ralph Victor Whitworth | M | 68 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Michael Heffernan | M | 59 | 2 anni | |
| Panayotis Sparaggis | M | - |
University of Massachusetts
| 5 anni |
| Srini Akkaraju Akkaraju | M | 56 | 11 anni | |
| Andy Bartlett | M | - |
University of Massachusetts
| 9 anni |
| Klaus Veitinger | M | 62 | 4 anni | |
| Wyche Fowler | M | 83 | 10 anni | |
| Steven J. Burakoff | M | 81 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Joseph Feczko | M | 75 | 6 anni | |
| Richard F. Syron | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Alan Smith | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 anni |
| Glenn Sblendorio | M | 68 | 9 anni | |
| Cornelius McGillicuddy | M | 83 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Henry E. Blair | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 26 anni |
| Wayne Boulais | M | 60 |
University of Massachusetts
| 7 anni |
| Marc Beer | M | 59 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 4 anni |
| Steven Gilman | M | 71 | 2 anni | |
| Louis J. Arcudi | M | 63 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 5 anni |
| Luca Benatti | M | 63 | 9 anni | |
| Kevin Cameron | M | 55 | 11 anni | |
| Brian J. Krol | M | - |
University of Massachusetts
| 7 anni |
| Melissa Bradford-Klug | F | - | 1 anni | |
| Sue Salvemini | F | - |
University of Massachusetts
| 4 anni |
| Edward Eccles | M | - |
University of Massachusetts
| 4 anni |
| Scott Solomon | M | - |
University of Massachusetts
| 4 anni |
| Jordan Tuchek | M | - |
Southern New Hampshire University
| 2 anni |
| James Costos | M | 61 |
University of Massachusetts
| 4 anni |
| Angie Cotterman | F | - |
Southern New Hampshire University
| 4 anni |
| Mitchell Boyarsky | M | - |
University of Massachusetts
| 4 anni |
| Kevin McNally | M | 55 |
University of Massachusetts
| 4 anni |
| Brett Jenks | M | - |
University of Massachusetts
| 3 anni |
| Eric Keisman | M | - |
University of Massachusetts
| 4 anni |
| Jeffrey B. Bernstein | M | 55 |
University of Massachusetts
| 4 anni |
| Cassidy Huckins | F | - |
Southern New Hampshire University
| 4 anni |
| Daniel Ngai | M | - |
University of Massachusetts
| 4 anni |
| Paula Drake | F | - |
University of Massachusetts
| - |
| James Spalding | M | 57 |
University of Massachusetts
| 4 anni |
| Emma Stewart | F | - |
Southern New Hampshire University
| 4 anni |
| James Lampert | M | - |
University of Massachusetts
| 4 anni |
| Maggie M. Burke | F | - |
University of Massachusetts
| 4 anni |
| Mark M. Andrew | M | - |
University of Massachusetts
| 4 anni |
| Aaron von Staats | M | 58 |
University of Massachusetts
| 4 anni |
| Rajeev Bhalla | M | 61 |
University of Massachusetts
| 4 anni |
| Peter deSilva | M | 62 |
University of Massachusetts
| 5 anni |
| Dean J. Breda | M | - |
University of Massachusetts
| 4 anni |
| Daniel Ernst | M | - |
University of Massachusetts
| 4 anni |
| Jonathan Duskin | M | 56 |
University of Massachusetts
| 4 anni |
| Sean Nelen | M | - |
University of Massachusetts
| 3 anni |
| Allen Fuqua | M | - |
University of Massachusetts
| 2 anni |
| David M. Lewis | M | 54 |
University of Massachusetts
| 4 anni |
| Beth A. Gorman | F | - |
University of Massachusetts
| 5 anni |
| Gil Penchina | M | - |
University of Massachusetts
| 4 anni |
| John N. Desmond | M | - |
University of Massachusetts
| 4 anni |
| John Schwartz | M | - |
University of Massachusetts
| 4 anni |
| Michael P. Cloherty | M | - |
University of Massachusetts
| 4 anni |
| Michael J. Hickey | M | - |
University of Massachusetts
| 4 anni |
| Wendy Berney Nelson | F | - |
University of Massachusetts
| 4 anni |
| Peter Kawa | M | - |
University of Massachusetts
| 4 anni |
| Dave Kelly | M | - |
University of Massachusetts
| 4 anni |
| Jim Miller | M | - |
University of Massachusetts
| 4 anni |
| Chuck Garabedian | M | - |
University of Massachusetts
| 4 anni |
| Samuel F. H. Jeffries | M | 60 |
University of Massachusetts
| 4 anni |
| Svetlana Yuryevna Barmina | F | 56 |
University of Massachusetts
| 4 anni |
| Güçlü Toker | M | 62 |
University of Massachusetts
| 4 anni |
| Marcin Jan Szumowski | M | - |
University of Massachusetts
| 4 anni |
| Jim McElroy | M | - |
University of Massachusetts
| 4 anni |
| Stephen James Klaus | M | - |
University of Massachusetts
| 6 anni |
| Chik Weng Leong | M | 61 |
University of Massachusetts
| 3 anni |
| Philip J. Bryan | M | 59 |
University of Massachusetts
| 4 anni |
| Alex Yelensky | M | - |
University of Massachusetts
| 4 anni |
| Jen Yousif | F | - |
Southern New Hampshire University
| 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 99 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Daniel Paul Regan
- Contatti personali
